Viz.ai
Artificial intelligence software designed to detect strokes and vascular diseases in medical imaging scans.
What they do
The company develops cloud-based artificial intelligence algorithms that analyze CT scans for suspected large vessel occlusions and other acute conditions. It alerts specialists in real time to accelerate treatment decisions and coordinates care across hospital networks.
The record
- Vertical
- Imaging & Diagnostics
- Sub-segment
- Clinical AI triage
- Product type
- Software as a medical device
- Stage
- Series C+
- Headquarters
- San Francisco, USA
- Region
- North America
- Founded
- 2016
- Total funding
- $250M raised
Notable investors: Tiger Global Management, Insight Partners, Scale Venture Partners, Kleiner Perkins.